AMA (Anti Mitochondrial Antibody) - IFA

Primary biliary cholangitis (PBC) is a chronic autoimmune liver disease in which the immune system mistakenly attacks the bile ducts, resulting in bile buildup in the liver. This causes scarring of the liver and can even lead to liver failure. Antimicrobial antibodies (AMAs) are produced as a part of this autoimmune response and are present in up to 95% of PBC patients. The AMA (Anti Mitochondrial Antibody) - IFA test detects the presence of these AMAs, making it a highly specific marker of PBC.

This test may be recommended if symptoms of liver disease such as fatigue, itching, jaundice, and abnormal liver function tests (particularly alkaline phosphatase) are noticed. It may also be done for individuals with risk factors such as a family history of autoimmune liver diseases or other autoimmune disorders. Additionally, the AMA (Anti Mitochondrial Antibody) - IFA test can be used to monitor the progression of PBC and the response to treatment.

AMAs can also be found in a smaller percentage of individuals with other liver and autoimmune conditions, such as systemic lupus erythematosus (SLE) and rheumatoid arthritis, as well as in some healthy people. Hence, the AMA (Anti Mitochondrial Antibody) - IFA test results should be interpreted in conjunction with other tests and clinical findings to confirm a diagnosis.

An overnight fasting (8 to 12 hours) is preferred before the AMA (Anti Mitochondrial Antibody) - IFA test. Inform your doctor about all the medicines and supplements you take, as some of them may affect the test results and need to be adjusted or temporarily discontinued before the test. 

Test result ranges may vary across laboratories. Abnormal test results require an expert interpretation; therefore, never try to self-medicate at home based solely on these results, and always consult a doctor for a proper understanding of the test results.